CXCL8 and Guillain-Barre syndrome: Furthermore, we report a possible prognostic value of IL8 in the long-term follow-up in GBS since pre-treatment levels of IL8 correlated with outcome as measured by GBS-ds at 6-months follow-up as well as with the EGOS score.